// App-Quantinova.ai

3138 : Changes in tumor cell-free DNA copy number instability (CNI) predict therapeutic response in metastatic cancers

Researchers

Presenter

  • Glen J. Weiss

Principal Investigators

  • Julia Beck

  • Donald P. Braun

  • Kirsten Bornemann-Kolatzki

  • Heather Barilla

  • Rhiannon Cubello

  • Ashish Sangal

  • Robert P. Whitehead

  • Madappa Kundranda

  • Vivek Khemka

  • Howard B. Urnovitz

  • Ekkehard Schutz

Medical Centers

  • Western Regional Medical Center, Cancer Treatment Centers of America, Goodyear, AZ

  • Chronix Biomedical, Gottingen, Germany

  • Cancer Treatment Centers of America, Zion, IL

Locations

  • United States

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Non Small Cell Lung cancer

  • Small cell lung cancer

  • Non-Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Colorectal Cancer

  • Esophageal Cancer

  • Hodgkin's Lymphoma

  • Lung Cancer

  • Lymphomas

  • Solid malignancies

  • Microphthalmia, syndromic, 9

Biomarkers

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved